Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | GRM8 | O00222 | 1/20 | 0.58 |
| ▸ | GRM6 | O15303 | 1/20 | 0.58 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.58 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.58 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.58 |
| ▸ | GRM5 | P41594 | 1/20 | 0.58 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.58 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.58 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.58 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.58 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.58 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.58 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.58 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.58 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.58 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.58 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.58 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Arginine SCHEMBL6668644 | 1.00 | GSR (0.58) | GSRCYP1A2GRM8GRM6GRIN2D | |
| Arginine SCHEMBL577728 | 1.00 | GSR (0.58) | GSRCYP1A2GRM8GRM6GRIN2D | |
| Arginine SCHEMBL6672058 | 1.00 | GSR (0.58) | GSRCYP1A2GRM8GRM6GRIN2D | |
| Arginine SCHEMBL424415 | 1.00 | GSR (0.58) | GSRCYP1A2GRM8GRM6GRIN2D | |
| Arginine SCHEMBL4749671 | 1.00 | GSR (0.58) | GSRCYP1A2GRM8GRM6GRIN2D | |
| Arginine SCHEMBL578155 | 1.00 | GSR (0.58) | GSRCYP1A2GRM8GRM6GRIN2D | |
| Arginine SCHEMBL6803653 | 1.00 | GSR (0.58) | GSRCYP1A2GRM8GRM6GRIN2D | |
| Arginine SCHEMBL2582854 | 1.00 | GSR (0.58) | GSRCYP1A2GRM8GRM6GRIN2D | |
| Arginine SCHEMBL578156 | 1.00 | GSR (0.58) | GSRCYP1A2GRM8GRM6GRIN2D | |
| Arginine SCHEMBL3338199 | 0.98 | GSR (0.56) | GSRCYP1A2GRM8GRM6GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 739 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704896-A1 | METHODS FOR SELECTING EXCIPIENTS AND FOR PREPARING HIGH CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS AND OTHER FORMULATIONS COMPRISING PROTEINS | Regeneron Pharmaceuticals, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4665394-A2 | ANTI-TL1A ANTIBODY COMPOSITIONS AND METHODS OF TREATMENT IN THE KIDNEY | Prometheus Biosciences, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4665393-A2 | ANTI-TL1A ANTIBODY COMPOSITIONS AND METHODS OF TREATING SKIN | Prometheus Biosciences, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4665767-A2 | ANTI-TL1A ANTIBODY COMPOSITIONS AND METHODS OF TREATMENT IN THE BILE DUCT | Prometheus Biosciences, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4665395-A1 | ANTI-TL1A ANTIBODY COMPOSITIONS AND METHODS OF TREATMENT IN THE LIVER | Prometheus Biosciences, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| US-20250340660-A1 | ANTI-CD30L ANTIBODIES, FORMULATIONS THEREFOR, AND USES THEREOF | PROMETHEUS BIOSCIENCES, INC. (US) | 2025-11-06 | — | — | US | claimed |
| WO-2025127595-A1 | COSMETIC COMPOSITION FOR SKIN SOOTHING | 주식회사 엘지생활건강 | 2025-06-19 | — | — | WO | claimed |
| EP-4562050-A1 | ANTI-CD30L ANTIBODIES, FORMULATIONS THEREFOR, AND USES THEREOF | Prometheus Biosciences, Inc. (US) | 2025-06-04 | — | — | EP | claimed |
| CN-119948058-A | Anti-CD 30L antibodies, formulations thereof and uses thereof | 普罗米修斯生物科学公司 | 2025-05-06 | — | — | CN | claimed |
| CN-114728064-B | Antibody-containing formulations | 中外制药株式会社 | 2025-05-06 | — | — | CN | claimed |
| EP-0750493-B1 | METHOD FOR MAKING CHEWABLE TABLETS BASED ON TROXERUTINE, CALCIUM CARBONATE, CALCIUM PHOSPHATE, ARGININE ASPARTATE, ARGININE GLUTAMATE, AMOXICILLIN, A COMBINATION OF CALCIUM CARBONATE AND MAGNESIUM CARBONATE, AND A COMBINATION OF ALUMINIUM HYDROXIDE AND MAGNESIUM HYDROXIDE | HI PHARMTECH (FR) | 1998-10-14 | — | — | EP | claimed |
| US-5817472-A | SOLID SUPPORT, DIPSTICK, ATTRACTANTS, CHEMOTAXIS OR ELECTROTAXIS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1998-10-06 | — | — | US | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| EP-0663015-A4 | DETECTION OF MOTILE ORGANISMS IN A SAMPLE. | UNIV AUSTRALIAN (AU) | 1997-04-02 | — | — | EP | claimed |
| EP-0663015-A1 | DETECTION OF MOTILE ORGANISMS IN A SAMPLE | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1995-07-19 | — | — | EP | claimed |
| WO-1994008042-A1 | DETECTION OF MOTILE ORGANISMS IN A SAMPLE | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1994-04-14 | — | — | WO | claimed |
| WO-1991015584-A1 | TRYPANOSOMA CRUZI RECOMBINANT ANTIGENS AND SYNTHETIC PEPTIDES FOR UTILIZATION IN THE IMMUNOLOGICAL DIAGNOSIS OF CHAGAS DISEASE | Fundação Oswaldo Cruz (Fiocruz) (BR) | 1991-10-17 | — | — | WO | claimed |
| US-4734222-A | Composition and method for cleaning soft and hard contact lenses | CIBA-GEIGY CORPORATION (US) | 1988-03-29 | — | — | US | claimed |
| EP-0122400-B1 | SWEETENER COMPOSITION AND SWEETENING METHOD | Takeda Chemical Industries, Ltd. (JP) | 1987-07-22 | — | — | EP | claimed |
| EP-0122400-A1 | Sweetener composition and sweetening method | Takeda Chemical Industries, Ltd. (JP) | 1984-10-24 | — | — | EP | claimed |